CGEN

Compugen Stock Price

9.55
-0.81 (-7.82%)
Upgrade to Real-Time
Regular Market
9.55
Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Compugen Ltd CGEN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.81 -7.82% 9.55 11:36:09
Open Price Low Price High Price Close Price Prev Close
10.83 9.55 10.99 10.36
Bid Price Ask Price Spread News
9.54 9.55 0.01 1 1
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
12,799 1,407,848 $ 10.16 $ 14,298,066 1,375,352 5.94 - 19.90
Last Trade Time Type Quantity Stock Price Currency
11:36:11 37 $ 9.55 USD

Compugen Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 789.73M 82.69M 57.28M $ - $ - -0.43 -35.10
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Compugen News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CGEN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week12.8413.529.3511.201,860,531-3.29-25.62%
1 Month11.6814.179.3512.281,191,527-2.13-18.24%
3 Months12.7515.169.3512.701,277,412-3.20-25.1%
6 Months18.6819.909.3514.361,288,557-9.13-48.88%
1 Year9.1619.905.9413.971,324,7190.394.26%
3 Years3.4019.902.0011.61602,1846.15180.88%
5 Years4.8119.902.0010.73415,2954.7498.54%

Compugen Description

Compugen Ltd is a therapeutic discovery company. It is involved in the business of using its predictive discovery infrastructure to identify novel drug targets and develop biologics. The firm's therapeutic pipeline mainly consists of early-stage immuno-oncology programs aimed at harnessing the immune system to fight cancer. It focuses on immune checkpoint target candidates which are predicted to serve drug targets for cancer immunotherapies addressing various cancer types and also autoimmune diseases.


Your Recent History
NASDAQ
CGEN
Compugen
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.